DexCom Reports Positive CONNECT Data for Non-Insulin Diabetes

DXCM reports positive CONNECT trial results as Dexcom G7 improves HbA1c and time in range in adults with Type 2 diabetes not using insulin.

ADA26: Dexcom’s G7 CGM helps TD2 diabetics not on insulin manage glucose levels

Dexcom anticipates that the findings could drive a shift in the standard of care for type 2 diabetes patients who do not use ...
STAT

Are glucose monitors a good thing for 2-year-olds? Experts look at risks, benefits

The newly approved over-the-counter CGM offers a new approach to tackling childhood obesity but also raises a host of ...
Business Insider

ROSEN, LEADING TRIAL ATTORNEYS, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DXCM

New York, New York--(Newsfile Corp. - September 7, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between January 8, ...
Morning Overview on MSN

The FDA cleared the first over-the-counter glucose monitor made for children

Parents of young children with elevated blood sugar now have a new option that does not require a doctor’s prescription. The ...

DexCom Expands Beyond CGMs With CONNECT Results AI Apps And Nutrisense Deal

DexCom (NasdaqGS:DXCM) reported new clinical data from its CONNECT trial on the Dexcom G7 continuous glucose monitoring system in adults with Type 2 diabetes not using insulin. The company introduced ...